NCT07126249View on ClinicalTrials.gov

A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

June 6, 2025

Study Completion Date

June 16, 2025

Conditions
Pharmacokinetics
Interventions
DRUG

pimicotinib capsules

pimicotinib capsules

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Abbisko Therapeutics Co, Ltd

INDUSTRY

NCT07126249 - A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter